Differential serum neutralisation of omicron sublineages in patients receiving prophylaxis with tixagevimab-cilgavimab

Lancet Infect Dis. 2023 May;23(5):528-530. doi: 10.1016/S1473-3099(23)00208-6. Epub 2023 Apr 5.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal*
  • Humans
  • SARS-CoV-2* / drug effects

Substances

  • Antibodies, Monoclonal
  • cilgavimab
  • tixagevimab

Supplementary concepts

  • SARS-CoV-2 variants